RecruitingNCT04458649
Continuous Glucose Monitoring in Infants
Sponsor
University of California, San Diego
Enrollment
200 participants
Start Date
Oct 1, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to employ continuous glucose monitoring to measure glucose profiles in newborn infants.
Eligibility
Min Age: 1 HourMax Age: 2 Hours
Inclusion Criteria3
- Mother at least 18 years of age
- Infants born either appropriate for gestational age (AGA) or large for gestational age (LGA)
- Skin fold over superior gluteus area at least 1 inch in thickness as measured by skin calipers
Exclusion Criteria6
- Infants born small for gestational age (SGA)
- Infant birth weight \<2.5 kg
- Infant BMI \<10th percentile on Olsen chart
- Infants born \<38 weeks gestation
- Infants with concern for intrauterine growth restriction (IUGR) and short femur length based on ultrasound
- Mother is non-English speaking
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEDexcom continuous glucose monitor
Measurement of interstitial glucose
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04458649
Related Trials
Pasteurised Donor Human Milk Supplementation for Term Babies
NCT069931034 locations
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
NCT066433511 location
The Feasibility of Cream for Treatment of Neonatal Hypoglycemia
NCT072174831 location
Continuous Glucose Monitoring in At-Risk Newborns
NCT043860051 location
Blood Glucose in Pregnant Non-diabetic Women During Treatment With Betamethasone for Fetal Lung Maturation
NCT067943071 location